All Products
  • Antibodies
  • Kits
  • Peptides
  • Proteins
  • Biochemicals
CH
cAMP/ cGMP/ Protein A/ β-Actin/ BSA/ Ddx4/ APOE/ TAU pT181/ TAU pT217/ Tau 1-441/ Aβ1-40/ Aβ1-42/ α-Syn/ GFAP/ IL/ CD/ 标记试剂盒/ GFP/ Flag/ 多肽合成服务/ /
Biosimilar Antibodies
Path：Home > Products > Antibodies > Biosimilar Antibodies
Products
Products
Research Grade Lutikizumab
All
  • Catalog： TD-HF802026
  • Clonality： mAb
  • Application： Research Grade Biosimilar
  • Synonyms： Bispecific, ABT-981, CAS: 1791411-57-8
  • Specification：
    1mg
  • Prices：
    ¥询价
Customized service consulting
Information
FAQ
Experimental program
Related Products
Bibliography

Research Grade Lutikizumab

Catalog No. TD-HF802026
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa (DVD-Ig)
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target IL1F1, Interleukin-1 alpha, IL1A, Hematopoietin-1, IL-1 alpha, Interleukin-1 beta, IL1B, Catabolin, IL1F2, IL-1 beta
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P01583 & P01584
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names Bispecific, ABT-981, CAS: 1791411-57-8
Background Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis.
Note For research use only. Not suitable for clinical or therapeutic use.